David Cooper

427 total citations
19 papers, 207 citations indexed

About

David Cooper is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, David Cooper has authored 19 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in David Cooper's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Glycosylation and Glycoproteins Research (2 papers). David Cooper is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Glycosylation and Glycoproteins Research (2 papers). David Cooper collaborates with scholars based in United States, Egypt and Denmark. David Cooper's co-authors include Anastasia Khvorova, Annabelle Biscans, Nicholas McHugh, Socheata Ly, Nathaniel B. Goldstein, Katherine Marks, Anthony D. Kelleher, Yiqun G. Shellman, Mayumi Fujita and David A. Norris and has published in prestigious journals such as JAMA, Nucleic Acids Research and PLoS ONE.

In The Last Decade

David Cooper

14 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Cooper United States	9	126	42	30	26	22	19	207
Peter D. Simone United States	7	148 1.2×	32 0.8×	37 1.2×	7 0.3×	18 0.8×	10	232
Woodrow E. Lomas United States	6	255 2.0×	48 1.1×	56 1.9×	20 0.8×	19 0.9×	10	331
Alicia Farmer United States	5	379 3.0×	20 0.5×	47 1.6×	21 0.8×	16 0.7×	5	436
Qihan Chen China	7	161 1.3×	33 0.8×	35 1.2×	21 0.8×	70 3.2×	13	275
Sean Paz United States	6	290 2.3×	44 1.0×	10 0.3×	29 1.1×	51 2.3×	7	338
Poorwa Awasthi India	5	182 1.4×	15 0.4×	63 2.1×	8 0.3×	34 1.5×	11	249
Elodie Bournique United States	7	261 2.1×	40 1.0×	63 2.1×	20 0.8×	51 2.3×	14	315
Nanping Ai China	8	231 1.8×	58 1.4×	29 1.0×	70 2.7×	34 1.5×	12	334
Ralf Sanzenbacher Germany	10	186 1.5×	176 4.2×	59 2.0×	21 0.8×	24 1.1×	19	345

Countries citing papers authored by David Cooper

Since Specialization

Citations

This map shows the geographic impact of David Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cooper more than expected).

Fields of papers citing papers by David Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cooper. The network helps show where David Cooper may publish in the future.

Co-authorship network of co-authors of David Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of David Cooper. A scholar is included among the top collaborators of David Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cooper. David Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

O’Reilly, Daniel, et al.. (2025). Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs. Nucleic Acid Therapeutics. 35(3). 137–149. 1 indexed citations

Belgrad, Jillian, Qi Tang, Ashley Summers, et al.. (2024). A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic Acids Research. 52(11). 6099–6113. 8 indexed citations

Gilbert, James W., Zachary Kennedy, Bruno M.D.C. Godinho, et al.. (2024). Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs. Molecular Therapy — Nucleic Acids. 35(3). 102291–102291. 3 indexed citations

Kelly, Karen, Jonathan Lee, Dimas Echeverria, et al.. (2023). Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo. Nucleic Acids Research. 52(2). 977–997. 10 indexed citations

Fakih, Hassan H., Qi Tang, Ashley Summers, et al.. (2023). Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity. Molecular Therapy — Nucleic Acids. 34. 102080–102080. 8 indexed citations

Tang, Qi, Jacquelyn Sousa, Dimas Echeverria, et al.. (2022). RNAi-based modulation of IFN-γ signaling in skin. Molecular Therapy. 30(8). 2709–2721. 18 indexed citations

Biscans, Annabelle, Socheata Ly, Nicholas McHugh, David Cooper, & Anastasia Khvorova. (2022). Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo. Journal of Controlled Release. 349. 831–843. 30 indexed citations

Cooper, David, et al.. (2016). Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity. Acta Crystallographica Section F Structural Biology Communications. 72(10). 762–771. 4 indexed citations

Ahlenstiel, Chantelle, Katherine Marks, Stuart Turville, et al.. (2015). Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing. Molecular Therapy — Nucleic Acids. 4. e261–e261. 40 indexed citations

10.

Regenscheid, Andrew, et al.. (2014). Mobile, PIV, and Authentication. 2 indexed citations

11.

Cooper, David, et al.. (2014). Draft NIST Special Publication 800-157: Guidelines for Derived Personal Identity Verification (PIV) Credentials. 2 indexed citations

12.

Cooper, David, William T. Polk, Andrew Regenscheid, & Murugiah Souppaya. (2011). SP 800-147. BIOS Protection Guidelines.

13.

Goldstein, Nathaniel B., Katie Partyka, David Cooper, et al.. (2011). The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53. PLoS ONE. 6(8). e24294–e24294. 33 indexed citations

14.

Polk, William T., et al.. (2010). SP 800-78-3. Cryptographic Algorithms and Key Sizes for Personal Identification Verification.

15.

Chandramouli, Ramaswamy, et al.. (2010). SP 800-73-3. Interfaces for Personal Identity Verification. 1 indexed citations

16.

Resnick, Daniel K., Neil M. Resnick, William Welch, & David Cooper. (1999). Differential expressions of CD44 variants in tumors affecting the central nervous system. Molecular Diagnosis. 4(3). 219–232. 14 indexed citations

17.

Dhir, Rajiv, et al.. (1997). CD44 expression in benign and neoplastic human prostates*. Molecular Diagnosis. 2(3). 197–204. 11 indexed citations

18.

Cooper, David. (1992). Hypopigmented Macules. Archives of Dermatology. 128(9). 1269–1269. 12 indexed citations

19.

Israel, Harold L., et al.. (1964). Fibrinolysin Treatment of Thromboembolism. JAMA. 188(7). 628–31. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact